1. Blinatumomab administered concurrently with oral tyrosine kinase inhibitor therapy is a well-tolerated consolidation strategy and eradicates measurable residual disease in adults with Philadelphia chromosome positive acute lymphoblastic leukemia. (April 2019) Authors: King, Amber C.; Pappacena, Jeremy J.; Tallman, Martin S.; Park, Jae H.; Geyer, Mark B. Journal: Leukemia research Issue: Volume 79(2019) Page Start: 27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cobimetinib‐induced "dropped head syndrome" and subsequent disease management in an Erdheim‐Chester patient. Issue 10 (10th September 2019) Authors: King, Amber C.; Diamond, Eli L.; Orozco, Jennifer S.; Morse, Hannah R.; Ouyang, Linda L.; Schöder, Heiko; Rampal, Raajit K. Journal: Clinical case reports Issue: Volume 7:Issue 10(2019) Page Start: 1989 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Multicenter evaluation of efficacy and toxicity of venetoclax‐based combinations in patients with accelerated and blast phase myeloproliferative neoplasms. Issue 1 (29th October 2021) Authors: King, Amber C.; Weis, Taylor M.; Derkach, Andriy; Ball, Somedeb; Pandey, Manu; Mauro, Michael J.; Goldberg, Aaron D.; Stahl, Maximilian; Famulare, Christopher; Tallman, Martin S.; Wang, Eunice S.; Kuykendall, Andrew T.; Rampal, Raajit K. Journal: American journal of hematology Issue: Volume 97:Issue 1(2022) Page Start: E7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. No Loose Ends: A Review of the Pharmacotherapy of Hairy Cell and Hairy Cell Leukemia Variant. Issue 9 (September 2019) Authors: King, Amber C.; Kabel, Charlene C.; Pappacena, Jeremy J.; Stump, Sarah E.; Daley, Ryan J. Journal: Annals of pharmacotherapy Issue: Volume 53:Issue 9(2019) Page Start: 922 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Real-world analysis of the safety/tolerability of gilteritinib in combination with mold-active azole prophylaxis. (November 2022) Authors: King, Amber C.; Derkach, Andriy; Weis, Taylor M.; Stump, Sarah E.; Ciervo, Jenna R.; Ranaghan, Coleen P.; Stein, Eytan S. Journal: Leukemia research Issue: Volume 122(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The ABCs of Immunotherapy for Adult Patients With B-Cell Acute Lymphoblastic Leukemia. Issue 3 (March 2018) Authors: Horvat, Troy Z.; Seddon, Amanda N.; Ogunniyi, Adebayo; King, Amber C.; Buie, Larry W.; Daley, Ryan J. Journal: Annals of pharmacotherapy Issue: Volume 52:Issue 3(2018) Page Start: 268 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The use of Erwinia asparaginase for adult patients with acute lymphoblastic leukemia after pegaspargase intolerance. (November 2016) Authors: Horvat, Troy Z.; Pecoraro, Joshua J.; Daley, Ryan J.; Buie, Larry W.; King, Amber C.; Rampal, Raajit K.; Tallman, Martin S.; Park, Jae H.; Douer, Dan Journal: Leukemia research Issue: Volume 50(2016:Nov.) Page Start: 17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant. Issue 14 (6th December 2021) Authors: Bewersdorf, Jan Philipp; Derkach, Andriy; Gowda, Lohith; Menghrajani, Kamal; DeWolf, Susan; Ruiz, Josel D.; Ponce, Doris M.; Shaffer, Brian C.; Tamari, Roni; Young, James W.; Jakubowski, Ann A.; Gyurkocza, Boglarka; Chan, Alexander; Xiao, Wenbin; Glass, Jacob; King, Amber C.; Cai, Sheng F.; Daniy... Journal: Leukemia & lymphoma Issue: Volume 62:Issue 14(2021) Page Start: 3394 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Venetoclax: A First-in-Class Oral BCL-2 Inhibitor for the Management of Lymphoid Malignancies. (May 2017) Authors: King, Amber C.; Peterson, Tim J.; Horvat, Troy Z.; Rodriguez, Mabel; Tang, Laura A. Journal: Annals of pharmacotherapy Issue: Volume 51:Number 5(2017:May) Page Start: 410 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗